T1	p 83 111	seasonal allergic rhinitis .
T2	p 264 300	seasonal allergic rhinitis ( SAR ) .
T3	p 504 661	Private practices and hospital clinics in Ontario , Quebec and Manitoba . POPULATION Two hundred and eighty-four out-patients with SAR , who were symptomatic
T4	p 681 715	season , volunteered for enrolment
T5	p 1082 1085	and
T6	p 1594 1599	SAR .
T7	i 20 30	budesonide
T8	i 42 57	with budesonide
T9	i 171 181	budesonide
T10	i 213 223	budesonide
T11	i 367 374	devices
T12	i 987 997	budesonide
T13	i 1244 1245	.
T14	i 1486 1499	of budesonide
T15	i 1519 1529	budesonide
T16	i 1623 1652	budesonide powder formulation
T17	o 273 281	allergic
T18	o 326 336	patients '
T19	o 389 404	quality of life
T20	o 535 542	clinics
T21	o 546 562	Ontario , Quebec
T22	o 673 680	ragweed
T23	o 745 776	Mean daily nasal symptom scores
T24	o 891 899	symptoms
T25	o 1026 1050	non-nasal adverse events
T26	o 1072 1096	epistaxis and headache .
T27	o 1202 1223	less nasal irritation
T28	o 1341 1352	Improvement
T29	o 1356 1371	quality of life
T30	o 1396 1402	visits
T31	o 1553 1557	safe
T32	o 1562 1573	efficacious